Suchergebnisse - "Fromm, Jonathan R"

PubPharm (115)

1

CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells

enthalten in: Cancer biology & therapy | 2024

von Wang, H. | Koob, T. | Fromm, J. | +3

2

Use of CD32, CD44 and CD71 to differentiate follicular lymphoma and diffuse large B-cell lymphoma subtypes by flow cytometry

enthalten in: Journal of clinical pathology | 2024

von Schwarz, L. | Love, J. | Naresh, K. | +2

3

Pembrolizumab With R-CHOP in Previously Untreated DLBCL : Sustained, High Efficacy, and Safety With Long-Term Follow-Up

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Ho, C. | Gopal, A. | Till, B. | +12

4

A Review of the Flow Cytometric Findings in Classic Hodgkin Lymphoma, Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte-Rich Large B Cell Lymphoma

enthalten in: Clinics in laboratory medicine | 2023

von Ally, F. | Gajzer, D. | Fromm, J.

5

Predictors of risk of relapse in classic Hodgkin lymphoma

enthalten in: Journal of clinical pathology | 2023

von Fromm, J. | Tang, C. | Naresh, K.

6

MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte-predominant Hodgkin lymphoma

enthalten in: EJHaem | 2023

von Torabi, A. | Fromm, J. | Naresh, K.

7

Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL

enthalten in: Blood advances | 2023

von Graf, S. | Lynch, R. | Ujjani, C. | +11

8

Neutrophil to lymphocyte ratio and peripheral blood biomarkers correlate with survival outcomes but not response among head and neck and salivary cancer treated with pembrolizumab and vorinostat

enthalten in: Head & neck | 2023

von Pan, C. | Wu, Q. | Voutsinas, J. | +9

9

Peripheral lymphocytes and lactate dehydrogenase correlate with response and survival in head and neck cancers treated with immune checkpoint inhibitors

enthalten in: Cancer Medicine | 2023

von Pan, C. | Wu, Q. | Voutsinas, J. | +11

10

Peripheral lymphocytes and lactate dehydrogenase correlate with response and survival in head and neck cancers treated with immune checkpoint inhibitors

enthalten in: Cancer medicine | 2023

von Pan, C. | Wu, Q. | Voutsinas, J. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]